CREATE TABLE aptamers (
    id SERIAL PRIMARY KEY,
    aptamer varchar DEFAULT NULL,
    target varchar DEFAULT NULL,
    apt_type varchar DEFAULT NULL,
    length varchar DEFAULT NULL,
    sequence varchar DEFAULT NULL,
    effect varchar DEFAULT NULL,
    reference varchar DEFAULT NULL,
    structure varchar DEFAULT NULL
);
CREATE TABLE pending_list (
    id SERIAL PRIMARY KEY,
    email varchar NOT NULL,
    aptamer varchar DEFAULT NULL,
    target varchar DEFAULT NULL,
    apt_type varchar DEFAULT NULL,
    length varchar DEFAULT NULL,
    sequence varchar DEFAULT NULL,
    effect varchar DEFAULT NULL,
    reference varchar DEFAULT NULL,
    structure varchar DEFAULT NULL,
    status varchar DEFAULT 'Pending'
);
CREATE TABLE users (
    email VARCHAR PRIMARY KEY,
    password VARCHAR,
    admin boolean
);
CREATE TABLE comment (
    id SERIAL PRIMARY KEY,
    email VARCHAR,
    comment VARCHAR
);

INSERT INTO aptamers (
    aptamer, target, apt_type, length, sequence,
    effect, reference, structure
) VALUES
('TRIAP?', 'TrioGEFD2', 'Anticancer', '42', 'AREGADGAICGYNLATLVMLGPSERVFCPLCEPCSSDIYELM', 'specifically blocks GEFD2-exchange activity on RhoA in vitro and inhibits TrioGEFD2-mediated activation of RhoA in intact cells and specifically reverts the neurite retraction phenotype induced by TrioGEFD2 in PC12 cells', 'https://doi.org/10.1016/S0014-5793(02)02928-9', 'https://colab.research.google.com/drive/1ac7cyS31emsDW0cY7SoJXt4A5CYi6Vbx?usp=sharing'),
('TRIAP?', 'TRIO GEF2(cDNA)', 'Anticancer', '20', 'IPKKYERSSPLRRPVRMMLR', 'inhibit oncogenic rhogef', 'https://doi.org/10.1016/S0014-5793(02)02928-9', 'https://colab.research.google.com/drive/11qS2hkB5HfarkTpWv0zeXO8EFfngg-iG?usp=sharing'),
('TRIAP?', 'TRIO GEF2(cDNA)', 'Anticancer', '16', 'VLLREGRGFKVRLVVV', 'inhibit oncogenic rhogef', 'https://doi.org/10.1016/S0014-5793(02)02928-9', 'https://colab.research.google.com/drive/1GxkrU6UHE2qLIZs93F-g0AYvUl9alHij?usp=sharing'),
('Pep8', 'Cdk2', 'Anticancer', '20', 'YSFVHHGFFNFRVSWREMLA', 'Binds with CDK2 with Kd 38±5 nM in an evanescent wave instrument and inhibits CDK2 activity', 'https://doi.org/10.1038/380548a0', 'https://colab.research.google.com/drive/1gTDWIwW5Fu2nBMKJaCevgP5LIRnay9Jr?usp=sharing'),
('Pep104', 'Ras-V12', 'Anticancer', '20', 'FWQATLRLVSDKLILLYPDP', 'Prevents activation of Raf1', 'https://doi.org/10.1073/pnas.94.23.12473', 'https://colab.research.google.com/drive/18t9wIKtffAhXRsVQlqsxDwtai39PGJAg?usp=sharing'),
('Pep8', 'DmCdk1', 'Anticancer', '20', 'YSFVHHGFFNFRVSWREMLA', 'Binds to Cdk2 with kd in nanomolar range, resulting in suppression of the eye phenotypes', 'https://doi.org/10.1073/pnas.95.24.14266 ', 'https://colab.research.google.com/drive/1gTDWIwW5Fu2nBMKJaCevgP5LIRnay9Jr?usp=sharing'),
('DK2pep2', 'DmCdk2', 'Anticancer', 'NA', 'NA', 'Dk2pep2 interacts exclusively with DmCdk2 ', 'https://doi.org/10.1073/pnas.95.24.14266 ', ''),
('Pep2(I)', 'Ste5', 'Anticancer', '13', 'NA', 'pep2(I) interacts with\r\nSTE5p and inhibits the pheromone response pathway', 'https://doi.org/10.1073/pnas.95.13.7508 ', ''),
('AptC6', 'CBK1', 'Anticancer', 'NA', 'NA', 'AptC6 interacts with CBK1 conferring α-factor resistance. AptC6 also interacts with Ste5', 'https://doi.org/10.1073/pnas.96.15.8567 ', ''),
('P-7', 'Ste50', 'Anticancer', 'NA', 'NA', 'α-factor pheromone resistance', 'https://doi.org/10.1126/science.285.5427.591 ', ''),
('Apt5', 'E2F1', 'Anticancer', '19', 'RCVRCRFVVWIGLRVRCLV', 'Inhibits entry into S-phase by binding E2F with a motif that resembles a DP heterodimerization region, and blocking E2F''s association with DP', 'https://doi.org/10.1038/sj.onc.1202825', 'https://colab.research.google.com/drive/1IfxHSqpJx89GK2SoqjdgP3Wk30ytAfm6?usp=sharing '),
('E61-1', 'HPV16-E6', 'Anticancer', '20', 'GALVHKLFSQTSGSCLVCIS', ' Intracellular targeting of the HPV16 E6 oncoprotein by E6-binding peptide aptamers resulted in the apoptotic elimination of HPV16-positive cancer cells, whereas HPV-negative cells remains unaffected', 'https://doi.org/10.1073/pnas.11053889', 'https://colab.research.google.com/drive/1wtYx3LNk98lVQWjJXhiukFkM4hDj-Lwb?usp=sharing '),
('TRXA101Q', 'ThyA', 'Anticancer', 'NA', 'NA', 'Blocks thymidilate synthase causing thymine auxotrophy', 'https://doi.org/10.1073/pnas.040573397', ''),
('cRGDfV', 'Integrin', 'Anticancer', 'NA', 'NA', 'Probable interaction with alpha and beta3 integrins', 'https://pubmed.ncbi.nlm.nih.gov/11595688/', ''),
('Pep-apt55', 'HPV16-E7', 'Anticancer', '20', 'LNFIFDERSDIYVLWLILEG', 'Induction of selective apoptosis in E7positive cells in EBV 16', ' https://doi.org/10.1096/fj.00-0604fje', 'https://colab.research.google.com/drive/1M9XIq9SybWQKaH2iezZvFUDqCcUbiGXi?usp=sharing '),
('HAGBP', 'Grb2', 'Anticancer', '11', 'PPPPLPPRRRR', 'function by binding to the N-terminal SH3 domain of Grb2  thereby decreasing the proliferation of CML cells by affecting the Grb2-SoS-Ras–MAP kinase (Erk) pathway Kd: 2.72 ± 0.18  uM', 'https://doi.org/10.1182/blood.V98.6.1773', 'https://colab.research.google.com/drive/1dqYMASRP9mCo0i5kwzVYD_1KSGsis8lF?usp=sharing '),
('PNC-21', 'p53', 'Anticancer', '9', 'PPLSQETFS', 'Caused extensive tumour cell death by binding to mdm2 domain of human p53,', 'https://doi.org/10.1073/pnas.211280698', 'https://colab.research.google.com/drive/1_sUzP2gY1Czsj7h8i5CY_Y2hwFIXV1iv?usp=sharing '),
('TRIAP?', 'TRIO', 'Anticancer', '42', 'AREGADGAICGYNLATLVMLGPSERVFCPLCEPCSSDIYELM', 'specifically blocks GEFD2-exchange activity on RhoA  first isolated Rho–GEF inhibitor ', 'https://doi.org/10.1016/S0014-5793(02)02928-9', 'https://colab.research.google.com/drive/1_cFT0cEXrcB4w89hvNyAC9WWTHr_kRxG?usp=sharing '),
('Pep141', 'Ras-V12', 'Anticancer', '39', 'WWGYLGKLFQTETDGALGPRPMCFILVEAVFASAACDSC', ' These anti-Ras aptamters inhibit the interaction of oncogenic Ras with c-Raf1 in vitro and abolish EGF-stimulated activation of c-Raf1 in vivo. ', 'https://doi.org/10.1038/sj.onc.1205680', 'https://colab.research.google.com/drive/1o3HDse3BTm2bnX-jJ0fCqnYrfxMSXaFh?usp=sharing '),
('RIP2', 'Ras-Val19', 'Anticancer', '6', 'LGQGSW', ' Ras2-Val19 suppression thus reducing cell proliferation reduces the elevated levels of cAMP and suppresses the heat shock sensitivity characteristic of Ras-activated yeast cells ', ' https://doi.org/10.1002/bit.10538', 'https://colab.research.google.com/drive/1zlP7m1_MJCrz4c1nxSNy4y1ZTMlRA44E?usp=sharing '),
('KDI-1', 'EGFR', 'Anticancer', '20', 'VFGVSWVVGFWCQMHRRLVC', 'Aptamer KDI1 did not summarily block the EGF receptor tyrosine kinase activity but selectively interfered with the EGF-induced phosphorylation of the tyrosine residues 845 1068 and 1148 as well as the phosphorylation of tyrosine 317 of p46 Shc. EGFinduced phosphorylation of Stat3 at tyrosine 705 and Stat3-dependent transactivation were also impaired. ', '  https://doi.org/10.1074/jbc.M301629200', 'https://colab.research.google.com/drive/1ePhNST8v5fufgV4ygyj3m59y9hXSJUWg?usp=sharing '),
('PFKQ', 'XIAP', 'Anticancer', '6', 'CPFKQC', '50% reduced cell viability blocks caspase binding site', '  https://doi.org/10.1074/jbc.M210133200', 'https://colab.research.google.com/drive/1OG01BOq4WwGlCoMZw8Bd3sfFewvPAKgV?usp=sharing '),
('DBD1', 'Stat3', 'Anticancer', '20', 'PLTAVFWLIYVLAKALVTVC', 'specifically interacting with the Stat3 dimerization domain caused inhibition of DNA binding activity and suppression of transactivation by Stat3 in EGF-responsive cells. ', 'https://doi.org/10.1158/1541-7786.170.2.3', 'https://colab.research.google.com/drive/1LYwJJ8kAsQnS4fhTAHsYByMwaDRJo0dc?usp=sharing '),
('PPC', 'Pro-MMP9', 'Anticancer', '18', 'ADGACGYGRFSPPCGAAG', 'Inhibits either substrate binding or proenzyme activation, leading to an inhibition of cell migration and invasion.', ' https://doi.org/10.1074/jbc.M401601200', 'https://colab.research.google.com/drive/1BbQ9A6BlJYSNPtd-HfeO3VIhcrY3VA0D?usp=sharing '),
('SHPR190', 'HIV-rev', 'Anticancer', 'NA', 'NA', 'owns the dual property of penetrating within lymphocytes and of binding to SUMO 1 thus inhibiting viral replication', ' https://doi.org/10.1074/jbc.M311594200', ''),
('Pentratin', 'NA', 'Anticancer', '16', 'RQIKIWFQNRRMKWKK', 'Translocation through the cell membrane', 'https://doi.org/10.1016/S0021-9258(17)34080-2', 'https://colab.research.google.com/drive/15U0iEmoD9_uGIgLXIdLTTI3Qy-e-xJF4?usp=sharing '),
('Tat derived peptides', 'NA', 'Drug delivery', '11', 'YGRKKRRQRRR', 'promote the intracellular delivery of covalently bound proteins such as beta-galactosidase RNase A or horseradish peroxidase in several cell lines and tissues', ' https://doi.org/10.1074/jbc.272.25.16010', 'https://colab.research.google.com/drive/1zZpPW0LBkt1fta2k-ZLIhlUEz0nYCDxt?usp=sharing '),
('VP22', '', 'Drug delivery', '34', 'DAATATRGRSAASRPTERPRAPARSASRPRRPVE', 'intercellular transport', ' https://doi.org/10.1016/S0092-8674(00)81843-7', 'https://colab.research.google.com/drive/1kxHJhfNtkWjiCLWbGes6qZbuor82xTR0?usp=sharing '),
('Transportan', '', 'Drug delivery', '27', 'GWTLNSAGYLLGKINLKALAALAKKIL', 'uptake into the nuclei ', 'https://doi.org/10.1096/fsb2fasebj.12.1.67', 'https://colab.research.google.com/drive/1GhGZ-04fyiKstiJHc1E61c_nuVVOCCNU?usp=sharing '),
('MAP', '', 'Drug delivery', '18', 'KLALKLALKALKAALKLA', 'alpha-helical amphipathic model peptide involved in the uptake of ionic compounds into mammalian cells', 'https://doi.org/10.1016/S0005-2736(98)00161-8', 'https://colab.research.google.com/drive/1xTy2djYvfyuHeU4OOXhHeuJGNl0nPqOk?usp=sharing '),
('TP10', '', 'Drug delivery', '21', 'AGYLLGKINLKALAALAKKIL', 'penetrates into cell membrane no effect on GTPase activity in Rin m5F cell membranes.', 'https://doi.org/10.1016/S0005-2736(00)00216-9', 'https://colab.research.google.com/drive/14irxpcpJJRao__iGQbtFJmgKtBYfyarN?usp=sharing '),
('9R', '', 'Drug delivery', '9', 'RRRRRRRRR', 'enhance cellular uptake by the guanidinium groups than either charge or backbone structure.', 'https://doi.org/10.1073/pnas.97.24.13003', 'https://colab.research.google.com/drive/1gU8rkyM_cR2EyCMFWTwMcXT_53m7_AUb?usp=sharing '),
('PTD-5', '', 'Drug delivery', '12', 'RRQRRTSKLMKR', 'It can be used to transfer therapeutic proteins and DNA for the treatment of a wide variety of diseases, including arthritis and cancer', 'https://doi.org/10.1006/mthe.2000.0137', 'https://colab.research.google.com/drive/1sXh9fvYMesYuACjge9-sU_PRyJbcc4VP?usp=sharing '),
('pVEC', '', 'Drug delivery', '18', 'LLIILRRRIRKQAHAHSK', 'helps in internalization of pVEC', 'https://doi.org/10.1006/excr.2001.5316', 'https://colab.research.google.com/drive/17ruqdTsvzcKmd51LzShGgG1IxvwJBucT?usp=sharing '),
('C6-14', 'Nr-13 protein', 'Anticancer', '20', 'RRGSPVLEASKAVDVLFLVL', ' Targets Nr-13 a Bcl-2 antiapoptotic protein involved in neoplastic transformation by the Rous sarcoma virus', 'https://doi.org/10.1038/sj.onc.1209832', 'https://colab.research.google.com/drive/1rRMyJaAryCEGtrEgVZP-OTxqJLR1o05L?usp=sharing '),
('M10b1', 'Nr-13 protein', 'Anticancer', '20', 'RRGSPVMEASKAVDVLFLAL', ' Targets Nr-13 a Bcl-2 antiapoptotic protein involved in neoplastic transformation by the Rous sarcoma virus', 'https://doi.org/10.1038/sj.onc.1209832', 'https://colab.research.google.com/drive/1Z6oC1HRoG_VvCv72LzeitRHBzNshRMRm?usp=sharing '),
('B16', 'Nr-13 and Bax', 'Anticancer', '20', 'PRGAPMWMRWVCQMLETMFL', 'Inhibit Nr-13 and Bax', 'https://doi.org/10.1038/sj.onc.1209832', 'https://colab.research.google.com/drive/14PYs8EzmnTPpVo5wTJpJd6up80SURDWQ?usp=sharing '),
('B16m3', 'Nr-13 protein', 'Anticancer', '20', 'PRGAPLWLCWVWQMLETMLP', ' Targets Nr-13 a Bcl-2 antiapoptotic protein involved in neoplastic transformation by the Rous sarcoma virus', 'https://doi.org/10.1038/sj.onc.1209832', 'https://colab.research.google.com/drive/1yTbeQnJ5NG0uJ_5H0TpThBqv4BtlO79h?usp=sharing '),
('AS1411', '', 'Drug delivery', '26', 'GGTGGTGGTGGTTGTGGTGGTGGTGG', 'macropinocytosis in cancer cells', 'https://doi.org/10.1021/acs.bioconjchem.8b00903', 'https://colab.research.google.com/drive/1zchl49_Y6vmJ4hLVr0A9alkwj3zQjdh5?usp=sharing '),
('AS1411', '', 'Drug delivery', 'NA', 'NA', 'Nucleolin acts as a receptor of AS1411  stimulating macropinocytosis, a process with potential applications in drug delivery.', 'https://doi.org/10.1158/0008-5472.CAN-10-0920', ''),
('A17', 'HSP70', 'Anticancer', '13', 'YCAYYSPRHKTTFA', 'increase sensitivity of tumor cells against anti cancer drugs', 'https://doi.org/10.1016/j.canlet.2017.01.015 ', 'https://colab.research.google.com/drive/193GV6w8qW9Y8fACY3k90Nf76qJWpJbp8?usp=sharing '),
('A8', 'HSP70', 'Anticancer', '8', 'SPWPRPTYA', 'increase sensitivity of tumor cells against anti cancer drugs and A8 and hsp70 association blocks the ability of exosomes to activate MDSCs', 'https://doi.org/10.1158/0008-5472.CAN-10-1443 ', 'https://colab.research.google.com/drive/1xJdtJsb10FQBmTuENpKzbCSh-DYAZDpC?usp=sharing '),
('A11', 'HSP70', 'Anticancer', '13', 'CIWVSDGKKLWRHA', 'increase sensitivity of tumor cells against anti cancer drugs', 'https://doi.org/10.1158/0008-5472.CAN-10-1443 ', 'https://colab.research.google.com/drive/1PyAhOFTcD-oizW6XmRGspCQam3X6KC4X?usp=sharing '),
('A12', 'HSP70', 'Anticancer', '13', 'CYTQYRKCQELTAA', 'increase sensitivity of tumor cells against anti cancer drugs', 'https://doi.org/10.1158/0008-5472.CAN-10-1443 ', 'https://colab.research.google.com/drive/1Gf77yWAll-yLCywDVIC-oX9nia86mKCr?usp=sharing '),
('rs3-PA', 'STAT3', 'Anticancer', '20', 'VRHSALHMAVGPLSWPARVS', 'inhibition of stat3  inhibits the migration and the angiogenic induction potential of cultured tumor cells useful in skin cancer', 'https://doi.org/10.1515/hmbci-2012-0014', 'https://colab.research.google.com/drive/1I2VIdK8yiUmy8ve16AxYSaJOJ7XThLSJ?usp=sharing '),
('Id1/3-PA7 ', 'Id1 and Id3', 'Anticancer', 'NA', 'NA', 'cell-cycle arrest and apoptosis in ovarian cancer cells ES-2 and PA-1', 'https://doi.org/10.1038/sj.bjc.6605897', ''),
('EE-02', 'cap-binding site of eIF4E', 'Anticancer', '11', 'ACEMGFFQDCG', 'specifically modulate eIF4E function by decreasing cap-dependent translation and cyclin D1 expression Kd: 406.2 ± 3.6 nM', 'https://doi.org/10.1039/D2CB00099G', 'https://colab.research.google.com/drive/1nq_XZIJYLiI1Qr-HFV80q7pvlQ_NRRIX?usp=sharing '),
('VH-DiFCAP-01', 'eIF4E', 'Anticancer', '15', 'PLPEMGFFTNIPAMV', 'recapitulates the interactions of EE-02 with the cap-binding site and forms additional interactions kd: 36.3 ±17.0 nM', 'https://doi.org/10.1039/D2CB00099G', 'https://colab.research.google.com/drive/1JJfFc663pGGlSMd2AvmL1E_CJIZXRCSO?usp=sharing '),
('Apt48', 'BCL-6', 'Anticancer', '10', 'HGPRDWCLFG', 'inhibit Bcl-6 ( bcl-6 allows cell proliferation and its constitutive expression promotes growth of lymphomas)', 'https://doi.org/10.1038/sj.onc.1209252', 'https://colab.research.google.com/drive/1Oe13CCMznTVUS-HFlfBa6z-Cqlelg0Sp?usp=sharing '),
('DUP-1', 'prostate-specific membrane antigen (PSMA)-negative cells', 'Anticancer', '12', 'FRPNRAQDYNTN', 'produce the dual-aptamer with RNA aptamer A10-3.2 modified tumor targeting gene and DOX delivery system', 'https://doi.org/10.1016/j.canlet.2016.10.003', 'https://colab.research.google.com/drive/1ykavXM7KtDCgT8Wv3Fj5YMORf59Oxsa6?usp=sharing '),
('p42', 'bind SoX2', 'Anticancer', '11', 'FSTLFFPLFFL', 'inhibit SoX2 which is found in high level in Esophageal squamous cell carcinoma (ESCC) , reduce priliferation and migration of ESCC  cells', ' https://doi.org/10.1016/j.ymthe.2020.01.012', 'https://colab.research.google.com/drive/1Gf77yWAll-yLCywDVIC-oX9nia86mKCr?usp=sharing '),
('AII-7', 'ErBb2 receptor', 'Anticancer', '41', 'LNFYRHGFLPNAVMASMLEVGPWFELLGLCGLAGHPLSSLR', 'Interacts with the intracellular domain of ERBb2 thus interfering AKT kinase in breast cancer cells and sensitizing it to Taxol', 'https://doi.org/10.1158/1541-7786.MCR-06-0046', 'https://colab.research.google.com/drive/1Epl0cIq-IAo8mOjYo51DCfeQSgdf812I?usp=sharing '),
('Ag-11', 'ErBb2 receptor', 'Anticancer', '21', 'GLAHGVAIYTELPLTRMARGG', 'Interacts with the intracellular domain of ERBb2 thus interfering AKT kinase in breast cancer cells and sensitizing it to Taxol', 'https://doi.org/10.1158/1541-7786.MCR-06-0046', 'https://colab.research.google.com/drive/1VTcYD4xsCUvarcRuQCiMTBzN9gINKHEX?usp=sharing '),
('S5-DBD-PA', 'DNA-Binding domain of Stat-5', 'Anticancer', '12', 'QGSWTINISKRL', 'stat5 inactivation by interaction with DNA binding domain thus preventing target gene activation and proliferation in  breast cancer and prostate cancer', 'https://doi.org/10.3390/ph6080960', 'https://colab.research.google.com/drive/1yA8nAwsDceoclOjZJ6gMoV1JA64WVQHj?usp=sharing '),
('TRIPE32G', 'inhibits Tgat GEF', 'Anticancer', '42', 'AREGADGAICGYNLATLVMLGPSERVFCPLCGPCSSDIYELM', 'the first inhibitor of the Tgat oncogene and demonstrates that aptamers can be used to interfere with RhoGEF functions in vivo with exquisite specificity.', 'https://doi.org/10.1016/j.chembiol.2009.02.006', 'https://colab.research.google.com/drive/11L-EOvn30a1HeKAVnPyNjzLhSdilMsFq?usp=sharing '),
('pep6', 'Cdk2', 'diagnostic', '20', 'RVKLGYSFWAQSLLRCISVG', 'Detect cdks whose activity is important in proliferating and cancerous cells', 'https://doi.org/10.1021/ac802513n ', 'https://colab.research.google.com/drive/1Xb5CLCBtyys5AGjopm7hgzAFQsF_kIZS?usp=sharing '),
('pep9', 'CDK2', 'diagnostic', '30', 'QQRFVFSPSWFTCAGTSDFWGPEPLFDWTR', 'detect cdks whose activity is important in proliferating and cancerous cells', 'https://doi.org/10.1021/ac802513n ', 'https://colab.research.google.com/drive/14X1E-sll44IK4uAO_P5x904vdI1VBjVm?usp=sharing '),
('Trx-SARA', 'Smad2 and Smad3', 'Anticancer', '14', 'TIPPLQQAQASGAL', 'binds specifically to Smad2 and Smad3 and inhibited both TGF-β–induced reporter gene expression and epithelial-to-mesenchymal transition in NMuMG murine mammary epithelial cells', 'https://doi.org/10.1091/mbc.e05-10-0990 ', 'https://colab.research.google.com/drive/1Fl5s6V94sveMB4DoX08CeKbKvnAlheVo?usp=sharing '),
('NHBP-1', 'Hydrophobic single-wall carbon nanohorns (SWNHs)', 'drug delivery', '12', 'DYFSSPYYEQLF', 'Noncovalent modification of Single Wall carbon NanoHorns using a conjugate comprised of PEG and peptide aptamer endows hydrophobic oxSWNHs with a good dispersibility under aqueous conditions.', 'https://doi.org/10.1021/mp070022t ', 'https://colab.research.google.com/drive/1qSXg2l3CQ-P36vjgtD06__q0MfWw6fGg?usp=sharing '),
('Swiggle', 'intracellular domain of membrane type 1-metalloproteinase (MT1-MMP)', 'Anticancer', '10', 'GGLIPCYFMH', 'Increase cell surface expression of MT1-MMP and inhibits internalization', 'https://doi.org/10.1186/1471-2121-11-58 ', 'https://colab.research.google.com/drive/1bDtUosLJi1D1tg0i6_7WU8JKg_QrDeQ8?usp=sharing '),
('A13', 'HSP70', 'Anticancer', '13', 'YCAYYSPRHKTTFA', 'enhance the accumulation efficiency of HBP-based nanomedicines in vivo', 'https://doi.org/10.7150/ntno.27142 ', 'https://colab.research.google.com/drive/1QtpmHYP81DwfSwHEVQSUJpvjQMhttps://colab.research.google.com/drive/193GV6w8qW9Y8fACY3k90Nf76qJWpJbp8?usp=sharing '),
('FITC-PPLRINRHILTR', 'hCG', 'diagnostic', '12', 'PPLRINRHILTR', 'labelled with FITC and used as a probe in a graphene oxide (GO)-based fluorescent platform for the detection of hCG with a detection limit of 20 mIU/mL', 'https://doi.org/10.3390/s16101699 ', 'https://colab.research.google.com/drive/1jjih9VKjGFhMI39Gk1tFJdUHn3cvYPP0?usp=sharing '),
('p1', 'CK2?', 'Anticancer', '19', 'GKMNGVLPLAWPSLYLRLP', 'bind to CK2? with Kd 0.4 ?M and induce apoptosis in mammalian cells through the recruitment of a p53-dependent apoptosis pathway', 'https://doi.org/10.1038/sj.onc.1209722 ', 'https://colab.research.google.com/drive/1FmuYeHYkSA_rh5vj5peIj-oExRFyvwCy?usp=sharing '),
('PA11', 'HSP27', 'Anticancer', '13', 'QLSGWVGRCLNIN', 'Inhibit HSP27  dimerization and oligomerization and acted as negative regulators of the anti-apoptotic and cytoprotective activities of this protein inducing apoptosis-mediated cell death', 'https://doi.org/10.1038/onc.2011.73 ', 'https://colab.research.google.com/drive/1uG2YoYRU8fF2A0T0m9209xHkt_-XtnHu?usp=sharing '),
('PA50', 'HSP27', 'Anticancer', '8', 'YLLRRLCC', 'Inhibit HSP27  dimerization and oligomerization and acted as negative regulators of the anti-apoptotic and cytoprotective activities of this protein inducing apoptosis-mediated cell death', 'https://doi.org/10.1038/onc.2011.73 ', 'https://colab.research.google.com/drive/1J9Z6jighPWX6kNom3fzY2XBbLHjDSiwY?usp=sharing '),
('F79', 'RAD52', 'Anticancer', '13', 'VINLANEMFGYNG', 'synthetic lethality in breast, pancreatic, and ovarian carcinoma cells harboring BRCA1- or BRCA2-inactivating mutations', 'https://doi.org/10.1182/blood-2013-05-501072 ', 'https://colab.research.google.com/drive/1RHLs7g0KEl28ugjsASts_Ic8_Bf1XOah?usp=sharing '),
('Y315', 'RAD51', 'Anticancer', '16', 'ETRICKIPYDSPCLLEA', 'target Rad51 which is directly phosphorylated by BCR-ABL1 oncogenic kinase, preferentially detected in the nuclei of leukemia', 'https://doi.org/10.1182/blood-2010-09-307256 ', 'https://colab.research.google.com/drive/1_oPn0exihqU9z5700tNK2aedxpidih1N?usp=sharing '),
('CRV', 'Pro-MMP9', 'Anticancer', '18', 'ADGACRVYGPYLLCGAAG', 'inhibits the association of MMP-9 C-terminal domain with αVβ5 integrin blocking cell invasion and migration up to 50%', 'https://doi.org/10.1074/jbc.M401601200 ', 'https://colab.research.google.com/drive/1m7ZEh1E0SqsCL_MUK4uWLqP9cvgsmO_m?usp=sharing '),
('aptamer-72', 'Central domain of A20 protein of Vaccinia Virus', 'Antiviral', '8', 'RQLVLRTR', 'Binds with DNA Polymerase E9 and stops the viral DNA Polymerase activity.', 'https://doi.org/10.1016/j.antiviral.2009.02.191 ', 'https://colab.research.google.com/drive/1deKi4g41AqFnw70pwQgcyDzynPA3zE8H?usp=sharing '),
('NA', 'Receptor binding domain (RBD) of S-protein of CoV-2', 'Antiviral', '18', 'AKTFLDKFNHEADLFYQ', 'Mimics the ACE2 receptor due to similar binding sequences and binds to the s protein of SARS cov 2 with a predicted binding energy of − 6.6 kcal/mol', 'https://doi.org/10.1007/s11030-020-10171-6 ', 'https://colab.research.google.com/drive/1VcGIBHkykfh_DLnpaAq_IdmjHWJ5UpNx?usp=sharing '),
('PA34', 'DHBV core protein', 'Antiviral', '20', 'ASLGLRPMGWRRSMCMAMLR', 'forms coaggregates with DHBV core protein and transported to aggresomes ', 'https://doi.org/10.1074/jbc.M604258200 ', 'https://colab.research.google.com/drive/1VcGIBHkykfh_DLnpaAq_IdmjHWJ5UpNx?usp=sharing '),
('LEDGF/p75', 'HIV-1 Integrase', 'Antiviral', '19', 'WQCLTLTHRGFVLLTITVL', 'Binds to HIV-1 IN enzyme with Kd of approximately 10 μM and strongly inhibits the dimerization of IN protein.', 'https://doi.org/10.1016/j.jmb.2007.11.095 ', 'https://colab.research.google.com/drive/1LstkMnzsuBg8UqyQvdi7wIwM8C6CargW?usp=sharing '),
('A4', 'puL84 NLS of HCMV', 'Antiviral', '20', 'SSCNMGWDTPACCVWFPYWV', 'Interacts with the open reading frame of uL84 causing interference in protein interactions.', 'https://doi.org/10.1128/jvi.01378-09 ', 'https://colab.research.google.com/drive/1Af3wdNMs5goqTjFM5yvN2ofU_xtD1iPk?usp=sharing '),
('A8', 'puL84 NLS of HCMV', 'Antiviral', '20', 'MAVGLVLCDWWLGEYLLELA', 'Interacts with the open reading frame of uL84 causing interference in protein interactions.', 'https://doi.org/10.1128/jvi.01378-09 ', 'https://colab.research.google.com/drive/1tPvToTAkHA-DYNFxIMVBTZjSR4R6nMN8?usp=sharing '),
('A56', 'puL84 NLS of HCMV', 'Antiviral', '20', 'PVLQPALSLSCGPEPLLLSC', 'Interacts with the open reading frame of uL84 causing interference in protein interactions.', 'https://doi.org/10.1128/jvi.01378-09 ', 'https://colab.research.google.com/drive/1Uv5xFfxtPuY_5E3KNXoA7tD4AfNgyI2J?usp=sharing '),
('A110', 'puL84 NLS of HCMV', 'Antiviral', '20', 'IEVTFVNRRGDGAELWYLSA', 'Interacts with the open reading frame of uL84 causing interference in protein interactions.', 'https://doi.org/10.1128/jvi.01378-09 ', 'https://colab.research.google.com/drive/1uxrYmec6915d5zTXRjULGajQct-uTSVb?usp=sharing '),
('C1-1', 'HBV core protein', 'Antiviral', '20', 'SFYSVLFLWGTCGGFSHSWY', 'Binds to the HBV core protein and the HBV long-surface antigen L-HbsAg during envelopment of capsid Inhibiting replication and virion formation.', 'https://doi.org/10.1038/sj.onc.1204805 ', 'https://colab.research.google.com/drive/1ChhRErpiG95VxciUHbRca1y9lgtT444E?usp=sharing '),
('AmPep1', 'Replication origin loop structure of TYLCV', 'Antiviral', '16', 'SVGRKWRMKWAQMRQQ', 'Binds the replication origin loop structure of the TYLCV with Kd of 1.8 nM in LSRP blocking Viral replication', 'https://doi.org/10.1016/j.pestbp.2018.01.005 ', 'https://colab.research.google.com/drive/1qVnCI-kqy6TpeEX7xCnOVP9GiHteL87R?usp=sharing '),
('P6.1', 'ZIKV envelope protein', 'Diagnostic', '12', 'KQERNNWPLTWT', 'Detects ZIKV envelope protein in a FICT with a LOD of 20000 TCID50/mL', 'https://doi.org/10.1016/j.bios.2021.113768 ', 'https://colab.research.google.com/drive/1A7tjuWxFnlvmGGt__dRw5mt9Y1qPQMMd?usp=sharing '),
('P29.1', 'ZIKV envelope protein', 'Diagnostic', '11', 'KYTTSTLKSGV', 'Detects ZIKV envelope protein in a FICT with a LOD of 40000 TCID50/mL', 'https://doi.org/10.1016/j.bios.2021.113768 ', 'https://colab.research.google.com/drive/18WQQzA2gpSbhlZ3Xxb8FI5ISD8CaIy71?usp=sharing '),
('B2.33', 'ZIKV envelope protein', 'Diagnostic', '15', 'KRHVWVSLSYSCAEA', 'Detects ZIKV envelope protein in a FICT with a LOD of 40000 TCID50/mL', 'https://doi.org/10.1016/j.bios.2021.113768 ', 'https://colab.research.google.com/drive/1Eok1Vmfr3q1gm8kdBYcIerwZKmyeX_I1?usp=sharing '),
('P1', 'Haemagglutinin of H5N3', 'Diagnostic', '10', 'KASGYTFTSF', 'Mimics the CDRs from influenza A virus-neutralizing antibody and detects influenza hemagglutinin(HA) with a  LOD of 15.6 HAU/mL', 'https://doi.org/10.1166/jbn.2019.2772 ', 'https://colab.research.google.com/drive/1FVXJsM8AtvsaQINYsxW79SPx8_2aBpIu?usp=sharing'),
('HPV-16-L1', 'Anti HPV-16 antibody', 'Diagnostic', '15', 'NLASSNYFPTPSGSM', 'used as an affinity capture agent for an interdigitated platinum electrode array coated with functional polyaniline/MWCNT for electrochemical detection Anti-HPV antibodies with LOD of 490pM', 'https://doi.org/10.1021/acsomega.9b02885 ', 'https://colab.research.google.com/drive/1trljD0RaUDwWaqY03tTefciogK7_7sRI?usp=sharing'),
(' Z_10.8', 'ZIKV envelope protein', 'Diagnostic', '10', 'KRAVVSCAEA', 'detects ZIKV envelope protein in a FLISA with a LOD of 10000 TCID50/mL', 'https://doi.org/10.7150/thno.25955 ', 'https://colab.research.google.com/drive/1B2AseobFIYjAxfD6qNQpi3jeA7NIg4_N?usp=sharing '),
('Antibody derived Peptide Aptamer (ADPA)', 'Pro-inflammatory cytokine IL-6', 'Diagnostic', '36', 'CNRAGWGMGDCGSGSGCGFTFSSYRCGPGSAGGGSC', 'Mimics the binding regions of the CDR loops of antibody heavy chain detecting IL-6 in serum in a peptide-aptamer-based LSPRi immunoassay with a LOD of 4.6 pg/mL', 'https://doi.org/10.1021/acsami.2c14748', 'https://colab.research.google.com/drive/1JzUcKTaYqdECM-8RvMYD92dJG6AZj0Ux?usp=sharing '),
('E61-1', 'E6 oncoprotein of HPV-16 infected cervical keratinocytes', 'Diagnostic', '20', 'GALVHKLFSQTSGSCLVCIS', 'Binds to the E6 oncoprotein of HPV-16 in microarray format with a limit of detection of  13fmol', 'https://doi.org/10.1016/j.ab.2010.10.038 ', 'https://colab.research.google.com/drive/1QbixGFoXJgIKddA9AsQhAOdbCpfteXch?usp=sharing '),
('E7-4', 'E7 oncoprotein of HPV-16 infected cervical keratinocytes', 'Diagnostic', '20', 'YLRGSRLVCWGPASCPCFVY', 'Binds to the E7 oncoprotein of HPV-16 in microarray format with a limit of detection of 13fmol', 'https://doi.org/10.1016/j.ab.2010.10.038 ', 'https://colab.research.google.com/drive/1sxMQZRr5KLgZIGjbzS5eEQtL5BJA-L1Y?usp=sharing '),
('B2', 'E2 protein of CHIKV', 'Diagnostic', '12', 'ITPQSSTTEAEL', 'Specifically binds to CHIKV E2, but not to DENV & ZIKV with a LOD of 164ng/mL', 'https://doi.org/10.1186/s12985-023-02132-w \n\n', 'https://colab.research.google.com/drive/1kzw82BXHybfLj_EntIQFZVxLyaMba8sD?usp=sharing'),
('B3', 'E2 protein of CHIKV', 'Diagnostic', '8', 'DTQGSNWI', 'Detects CHIKV E in Serum & urine samples with a LOD of 57.8 and 147.3 ng/mL respectively', 'https://doi.org/10.1186/s12985-023-02132-w\n\n', 'https://colab.research.google.com/drive/1LyWqmvgkY05GxMsyBeP3izVTU1HmnQx3?usp=sharing');
